Elevated rates of intracerebral hemorrhage in individuals from a US clinical care HIV cohort

Neurology

Volumn 83, Issue 19, 2014, Pages 1705-1711

  Chow, Felicia C ^a   He, Wei ^d   Bacchetti, Peter ^b   Regan, Susan ^d   Feske, Steven K ^c   Meigs, James B ^d   Grinspoon, Steven K ^e   Triant, Virginia A ^d,e,f  

^a Departments of Neurology   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d Division of General Medicine   (United States)

^e Program in Nutritional Metabolism   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ARTICLE; BRAIN HEMORRHAGE; CD4 LYMPHOCYTE COUNT; CENTRAL NERVOUS SYSTEM INFECTION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; ENDOCARDITIS; FEMALE; HEALTH CARE SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; ICD-9-CM; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RISK FACTOR; UNITED STATES; VIRUS LOAD; AGE; CEREBRAL HEMORRHAGE; COHORT ANALYSIS; COMPLICATION; HEALTH CARE DELIVERY; HIV INFECTIONS; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; PROPORTIONAL HAZARDS MODEL; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA; VIROLOGY;

ADULT; AGE FACTORS; CEREBRAL HEMORRHAGE; COHORT STUDIES; DELIVERY OF HEALTH CARE; FEMALE; HIV INFECTIONS; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEX FACTORS; UNITED STATES;

EID: 84922243262     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000958     Document Type: Article

References (40)

1. Currier JS, Taylor A, Boyd F, et al. Coronary heart disease in HIV-infected individuals. J Acquir Immune Defic Syndr 2003;33:506-512.
2. Lang S, Mary-Krause M, Cotte L, et al. Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population. AIDS 2010;24:1228-1230.
3. Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab 2007;92:2506-2512.
4. Obel N, Thomsen HF, Kronborg G, et al. Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study. Clin Infect Dis 2007;44: 1625-1631.
5. Chow FC, Regan S, Feske S, Meigs JB, Grinspoon SK, Triant VA. Comparison of ischemic stroke incidence in HIV-infected and non-HIV-infected patients in a US health care system. J Acquir Immune Defic Syndr 2012; 60:351-358.
6. Rasmussen LD, Engsig FN, Christensen H, et al. Risk of cerebrovascular events in persons with and without HIV. AIDS 2011;25:1637-1646.
7. Silverberg MJ, Leyden WA, Xu L, et al. Immunodeficiency and risk of myocardial infarction among HIVpositive individuals with access to care. J Acquir Immune Defic Syndr 2014;65:160-166.
8. Evers S, Nabavi D, Rahmann A, Heese C, Reichelt D, Husstedt I-W. Ischaemic cerebrovascular events in HIV infection: a cohort study. Cerebrovasc Dis 2003; 15:199-205.
9. Corral I, Quereda C, Moreno A, et al. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors. Cerebrovasc Dis 2009;27:559-563.
10. Tirschwell DL, Longstreth WT. Validating administrative data in stroke research. Stroke 2002;33:2465-2470.
11. Triant VA, Meigs JB, Grinspoon SK. Association of C-reactive protein and HIV infection with acute myocar-dial infarction. J Acquir Immune Defic Syndr 2009;51: 268-273.
12. Zeng QT, Goryachev S, Weiss S, Sordo M, Murphy SN, Lazarus R. Extracting principal diagnosis, co-morbidity and smoking status for asthma research: evaluation of a natural language processing system. BMC Med Inform Decis Mak 2006;6:30.
13. Bergersen BM, Sandvik L, Dunlop O, Birkeland K, Bruun JN. Prevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naïve and HIV-negative controls: results from a Norwegian study of 721 patients. Eur J Clin Microbiol Infect Dis 2003;22:731-736.
14. Seaberg EC, Muñoz A, Lu M, et al. Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. AIDS 2005;19:953-960.
15. Palacios R, Santos J, García A, et al. Impact of highly active antiretroviral therapy on blood pressure in HIV-infected patients: a prospective study in a cohort of naive patients. HIV Med 2006;7:10-15.
16. De Socio GV, Ricci E, Maggi P, et al. Prevalence, awareness, treatment, and control rate of hypertension in HIV-infected patients: the HIV-HY study. Am J Hypertens 2014;2:222-228.
17. Sturgeon JD, Folsom AR, Longstreth WT, Shahar E, Rosamond WD, Cushman M. Risk factors for intracerebral hemorrhage in a pooled prospective study. Stroke 2007;38:2718-2725.
18. Feldmann E, Broderick JP, Kernan WN, et al. Major risk factors for intracerebral hemorrhage in the young are modifiable. Stroke 2005;36:1881-1885.
19. Woo D, Sauerbeck LR, Kissela BM, et al. Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study. Stroke 2002;33:1190-1195.
20. Howard G, Cushman M, Howard VJ, et al. Risk factors for intracerebral hemorrhage: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Stroke 2013;44:1282-1287.
21. Ariesen MJ, Claus SP, Rinkel GJE, Algra A. Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke 2003;34:2060-2065.
22. Centers for Disease Control and Prevention. Disparities in diagnoses of HIV infection between blacks/African Americans and other racial/ethnic populations: 37 states, 2005-2008. MMWR Morb Mortal Wkly Rep 2011;60:93-98.
23. Bhalla A, Wang Y, Rudd A, Wolfe CDA. Differences in outcome and predictors between ischemic and intrace-rebral hemorrhage: the South London stroke register. Stroke 2013;44:2174-2181.
24. Dennis MS. Outcome after brain haemorrhage. Cerebro-vasc Dis 2003;16(suppl 1):9-13.
25. Cole JW, Pinto AN, Hebel JR, et al. Acquired immunodeficiency syndrome and the risk of stroke. Stroke 2004; 35:51-56.
26. Ortiz G, Koch S, Romano JG, Forteza AM, Rabinstein AA. Mechanisms of ischemic stroke in HIV-infected patients. Neurology 2007;68:1257-1261.
27. Mochan A, Modi M, Modi G. Stroke in black South African HIV-positive patients: a prospective analysis. Stroke 2003;34:10-15.
28. Ovbiagele B, Nath A. Increasing incidence of ischemic stroke in patients with HIV infection. Neurology 2011; 76:444-4505.
29. Durand M, Sheehy O, Baril J-G, LeLorier J, Tremblay CL. Risk of spontaneous intracranial hemorrhage in HIV-infected individuals: a population-based cohort study. J Stroke Cerebrovasc Dis 2013;22:e34-e41.
30. Hsue PY, Deeks SG, Hunt PW. Immunologic basis of cardiovascular disease in HIV-infected adults. J Infect Dis 2012;205:S375-S382.
31. Triant VA. HIV infection and coronary heart disease: an intersection of epidemics. J Infect Dis 2012;205:S355-S361.
32. Strategies for Management of Antiretroviral Therapy SMART Study Group, El-Sadr WM, Lundgren JD, et al. CD41 count-guided interruption of antiretroviral treatment. N Engl J Med 2006; 355: 2283-2296.
33. Triant VA, Regan S, Lee H, Sax PE, Meigs JB, Grinspoon SK. Association of immunologic and virologic factors with myocardial infarction rates in a US healthcare system. J Acquir Immune Defic Syndr 2010;55:615-619.
34. Hsue PY, Lo JC, Franklin A, et al. Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation 2004;109:1603-1608.
35. Kaplan RC, Kingsley LA, Gange SJ, et al. Low CD41 T-cell count as a major atherosclerosis risk factor in HIV-infected women and men. AIDS 2008;22:1615-1624.
36. Lichtenstein KA, Armon C, Buchacz K, et al. Low CD4 1T Cell count is a risk factor for cardiovascular disease events in the HIV outpatient study. Clin Infect Dis 2010; 51:435-447.
37. Subramanian S, Tawakol A, Burdo TH, et al. Arterial inflammation in patients with HIV. JAMA 2012;308: 379-386.
38. Vinikoor MJ, Napravnik S, Floris-Moore M, Wilson S, Huang DY, Eron JJ. Incidence and clinical Features of cerebrovascular disease among HIV-infected adults in the Southeastern United States. AIDS Res Hum Retroviruses 2013;29:1068-1074.
39. Sabin CA, Ryom L, De Wit S, et al. Associations between immune depression and cardiovascular events in HIV infection. AIDS 2013;27:2735-2748.
40. Tien PC, Choi AI, Zolopa AR, et al. Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort. J Acquir Immune Defic Syndr 2010;55:316-322.